Crunchbase News
MAY 24, 2024
This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.
Crunchbase News
APRIL 2, 2024
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.
TechCrunch
NOVEMBER 16, 2022
Interestingly the model itself is not biotech-specific exactly but a derivative of the same “large language models” that have produced text production engines like GPT-3. ” Generate Biomedicines raises $370M Series B with a focus on protein-based drugs. Image Credits: Cradle.
Crunchbase News
SEPTEMBER 13, 2024
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
TechCrunch
FEBRUARY 28, 2023
” Going private: A guide to PE tech acquisitions Biotech proved a surprisingly bright spot in 2022’s startup correction Image Credits: Getty Images The hard science and regulations that govern biotech companies sets them far apart from other startups. biotech deals also set new records in 2022 for both median deal size, $33.5
TechCrunch
SEPTEMBER 14, 2023
Proteins, the natural molecules that carry out key cellular functions within the body, are the building blocks of all diseases. Characterizing proteins can reveal the mechanisms of a disease, including ways to slow it or potentially reverse it, while creating proteins can lead to entirely new classes of drugs and therapeutics.
Ooda Loop
NOVEMBER 20, 2024
Converge Bio, a generative AI platform for accelerated drug discovery and development, announced on Wednesday that it has raised $5.5 million in Seed funding, led by TLV Partners. in Seed funding to speed up drug discovery and development with GenAI appeared first on OODAloop.
Expert insights. Personalized for you.
128 
Let's personalize your content